JB Chemicals and Pharmaceuticals Ltd posted a 21.6% year-on-year (YoY) growth in net profit for the third quarter of FY25 at ₹162.5 crore, against ₹133.6 crore in the year-ago period.
JB Chemicals and Pharmaceuticals Ltd’s revenue from operations increased by 14.1%, reaching ₹963.5 crore from ₹844.5 crore in Q3 FY24. EBITDA at the operating level jumped 14.1% to ₹254.5 crore from ₹223.1 crore in the same quarter last year. EBITDA margin was flat at 26.4%, indicating stable operational dynamics. Earnings Before Interest, Tax, Depreciation, and Amortization (EBITDA) is an important metric to evaluate profitability and business performance.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
